Drug Manufacturers—Specialty & Generic Stocks
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3414 |  LFCR Lifecore Biomedical, Inc. - Common Stock | 6.43 USD | -0.16% | -1.83% | +60.75% | -3.45% | 243.40 M USD | ||
| 3434 |  SIGA SIGA Technologies Inc. - Common Stock | 3.28 USD | +0.61% | -3.53% | +6.84% | -61.41% | 235.67 M USD | ||
| 3476 |  AKBA Akebia Therapeutics, Inc. - Common Stock | 0.81 USD | -6.90% | -8.99% | -14.74% | -31.36% | 224.46 M USD | ||
| 3633 |  DERM Journey Medical Corporation - Common Stock | 5.95 USD | 0.00% | -12.88% | -19.38% | -20.67% | 167.94 M USD | ||
| 3644 |  ORGO Organogenesis Holdings Inc. - Class A | 1.28 USD | -3.03% | -8.57% | -18.47% | -70.16% | 164.70 M USD | ||
| 3755 |  CRDL Cardiol Therapeutics Inc. - Class A Common Shares | 1.30 USD | -1.52% | -17.72% | -41.18% | +19.27% | 130.33 M USD | ||
| 3757 |  OGI Organigram Global Inc. - Common Shares | 0.95 USD | -1.04% | -3.06% | -12.84% | -33.57% | 127.74 M USD | ||
| 3843 |  CPIX Cumberland Pharmaceuticals Inc. - Common Stock | 6.98 USD | +1.31% | -9.82% | +11.68% | +97.73% | 104.58 M USD | ||
| 3972 |  CTOR Citius Oncology, Inc. - Common Stock | 0.84 USD | -2.33% | -16.00% | -10.64% | -27.59% | 78.10 M USD | ||
| 4122 |  TLPH Talphera, Inc. - Common Stock | 1.08 USD | +2.86% | -2.70% | -10.00% | -14.96% | 56.06 M USD | ||
| 4129 |  INCR Intercure Ltd. - ordinary shares | 5.02 USD | -2.14% | -6.69% | -4.02% | +198.81% | 54.90 M USD | ||
| 4135 |  ZYBT Zhengye Biotechnology Holding Limited - Class A Ordinary Shares | 1.15 USD | -0.86% | -8.73% | -25.81% | -52.87% | 54.50 M USD | ||
| 4247 |  SCYX SCYNEXIS, Inc. - Common Stock | 4.22 USD | -11.72% | -20.68% | -12.45% | +427.50% | 41.99 M USD | ||
| 4254 |  CPHI China Pharma Holdings, Inc. Common Stock | 0.96 USD | +9.09% | +50.00% | +18.52% | +45.45% | 41.30 M USD | ||
| 4264 |  IXHL Incannex Healthcare Inc. - Common Stock | 3.20 USD | +0.63% | -3.61% | -0.93% | +644.19% | 40.14 M USD | ||
| 4348 |  RMTI Rockwell Medical, Inc. - Common Stock | 8.02 USD | -2.43% | -5.76% | +2.17% | +568.33% | 32.32 M USD | ||
| 4403 |  SHPH Shuttle Pharmaceuticals Holdings, Inc. - common stock | 5.56 USD | +18.05% | +36.27% | +62.57% | +414.81% | 26.49 M USD | ||
| 4444 |  TXMD TherapeuticsMD, Inc. - Common Stock | 2.01 USD | +0.50% | -1.47% | -5.19% | +84.40% | 23.26 M USD | ||
| 4452 |  AYTU Aytu BioPharma, Inc. - Common Stock | 2.05 USD | 0.00% | -1.44% | -4.65% | -19.61% | 22.28 M USD | ||
| 4587 |  BFRI Biofrontera Inc. - Common Stock | 0.92 USD | -2.13% | -12.38% | -39.87% | -9.80% | 13.66 M USD |
Nachrichten Drug Manufacturers—Specialty & Generic Stocks
Jefferies stuft Pacira Pharmaceuticals nach Viatris-Übernahme herab
Tilray: Rekordumsatz im ersten Quartal 2027, Aktie dennoch unter Druck
Helen of Troy meldet starke Q2-Ergebnisse und steigt zusammen mit Pacira Biosciences, Wolfspeed und anderen großen Aktien am Donnerstag an
Tilray Brands Q1 2027 Telefonkonferenz zum Ergebnisbericht Transkript
Dow fällt um mehr als 100 Punkte; Erstanträge auf Arbeitslosenhilfe in den USA gehen zurück
Pacira Pharmaceuticals-Aktie erreicht 52-Wochen-Hoch bei 36,32 USD
Biofrontera beantragt bei der FDA Zulassungserweiterung für Ameluz
Gainers Drug Manufacturers—Specialty & Generic Stocks
Losers Drug Manufacturers—Specialty & Generic Stocks
 SXTC China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares | 0.34 | -87.99% |
 SBFM Sunshine Biopharma Inc. - Common stock | 0.43 | -38.57% |
 BFRIW Biofrontera Inc. - Warrants | 0.0070 | -35.78% |
 SBFMW Sunshine Biopharma Inc. - Warrant | 0.0300 | -23.08% |
SCYX SCYNEXIS, Inc. - Common Stock | 4.22 | -11.72% |
 IMCC IM Cannabis Corp. - Common Shares | 1.72 | -9.47% |
 AKAN Akanda Corp. - Common Shares | 1.78 | -7.77% |
AKBA Akebia Therapeutics, Inc. - Common Stock | 0.81 | -6.90% |